IPA analysis match LCL, 1 year license extension (POP 11/18/2021 - 11/17/2022)
Ended Awarded
- Contract number
- 75N92B22F00003
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73 Part of Qiagen N.V.
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,999
Award facts
- Contract value 100% obligated
- $24,999.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Valencia, CA 91355, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a one-year license extension contract to Qiagen, LLC valued at $24,999 under a Blanket Purchase Agreement call mechanism. The contract period of performance runs from November 18, 2021 through November 17, 2022, with an ultimate completion date of April 30, 2022. The award was issued on a firm fixed price basis without a set-aside designation, and performance will occur in Valencia, California. Qiagen, LLC is a subsidiary of Netherlands-based Qiagen N.V., a multinational biotechnology company specializing in molecular diagnostics, sample preparation, and assay technologies that serve federal agencies across research, public health, and healthcare sectors.
This license extension represents a continuation of Qiagen's analytical software services, specifically the IPA Analysis Match platform, supporting the institute's research initiatives in musculoskeletal and skin disease research. As a recurring supplier to federal agencies, Qiagen maintains multiple indefinite delivery vehicles across government departments, enabling efficient procurement of specialized molecular diagnostics products, reagents, and software tools. The company's ability to compete effectively in open federal contracting is evidenced by its consistent receipt of awards without set-aside designations across multiple government agencies.
Quick answers
Who was awarded contract 75N92B22F00003?
75N92B22F00003 was awarded to Qiagen, LLC by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on November 3, 2021.
How much is contract 75N92B22F00003 worth?
The government has obligated $24,999 on 75N92B22F00003.
Is contract 75N92B22F00003 an order under another contract?
Yes. 75N92B22F00003 is a BPA call under HHSN263201500079B, a blanket purchase agreement.
Was contract 75N92B22F00003 competed?
The extent of competition for 75N92B22F00003 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award